This Pfizer Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

2026-03-11 23:46:06

RBC Capital analyst Trung Huynh initiated coverage on Pfizer Inc. (NYSE: PFE) with an Underperform rating and a $25 price target. This bearish outlook on Pfizer comes alongside several other analyst initiations for other companies. Top analysts also initiated coverage on Angel Studios Inc. (NYSE: ANGX) with a Buy rating, Alumis Inc. (NASDAQ: ALMS) with a Buy rating, Merck & Co Inc. (NYSE: MRK) with an Outperform rating, and Ceva Inc. (NASDAQ: CEVA) with a Buy rating.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.